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Aim: To investigate the role of cell adhesion molecules CD44v6 and CEA in the occurrence, development, and metastasis of colorectal
cancer (CRC).
Materials and methods: The expression of CD44v6 and CEA in 76 CRC tissues and 43 normal colon tissues was detected using an
immunohistological technique. The relationship between the 2 molecules’ expression and their pathologic characteristics, especially for
metastasis, was investigated. Furthermore, the relevance between the expression of CD44v6 and of CEA was also assessed.
Results: Expression of CD44v6 and CEA protein in CRC tissues was higher than in paracarcinoma tissue and normal colorectal mucosa
(both P < 0.001). Positive expression of CD44v6 in CRC was associated with lymph node metastasis, Dukes’ stage, and histological
differentiation. Higher expression intensity of CEA in CRC was related to lymph node involvement, distant metastasis, and invasion
depth. Combining analysis of CD44v6 and CEA can improve the sensitivity and specificity in evaluating the metastatic potential of CRC
(P < 0.05). There was no relevance between the expression of CD44v6 and CEA in CRC (P > 0.05).
Conclusion: CD44v6 is associated with the occurrence and lymph node metastasis of CRC. The expression of CEA is related to distant
metastasis of CRC positively. Combined analysis of CD44v6 and CEA can be used to evaluate metastasis of CRC.
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1. Introduction
Colorectal cancer (CRC) has traditionally been one of
the commonest disorders in western populations, while
cancers of the upper gastrointestinal tract (such as the
esophagus and stomach) and liver have predominated
in eastern populations (1). However, during the past
few decades, there have been remarkable changes in the
incidence of CRC in China, which is becoming higher
and higher. Metastasis and recurrence of CRC are the key
causes of death for the patients, so it is very important to
evaluate the potential for metastasis and recurrence in
CRC.
Both CD44v6 and CEA are cell adhesion molecules;
they can enhance metastasis by mediating the interaction
between cancer cells or between cancer cells and the
extracellular matrix (2). Our study was designed to detect
the different expression of CD44v6 and CEA in CRC
tissues, paracarcinoma tissue, and normal colorectal
mucosa by using an immunohistological technique, and
to observe the relationship between their expression and
* Correspondence: fengyedoctor2012@126.com
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clinical pathological features, especially metastasis. We
also studied the expressional dependability of CD44v6 and
CEA in CRC, and their functions and interactions during
the stages of initiation, development, and metastasis of
CRC.
2. Materials and methods
2.1. Patients and samples
A total of 76 samples of colorectal cancer, paracarcinoma,
and normal colorectal mucosa were collected from
patients operated on between March and November of
2011 in the Colorectal Surgical Department of the First
Affiliated Hospital of Zhejiang University. The 76 CRC
patients (average age: 58.9 years; 30 women and 46 men;
25 colonic cancer and 51 rectal cancer patients; 31 with
lymphoid invasion and 13 with distant metastasis) were
retrospectively identified by pathological diagnosis and
samples were collected from the tissues within 30 min
after being resected from the body. None of the patients
had been given chemical or radical therapies before
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the operation. Paracarcinoma tissue was defined as the
colorectal mucosa 1–2 cm from the edge of the cancer, and
the normal colorectal mucosa was defined as that more
than 10 cm from the edge of the cancer.
2.2. Immunohistochemistry
The samples were fixed in 10% formaldehyde, dehydrated
with ethanol, and then embedded in paraffin. Serial
sections were cut at 2-µm intervals and were collected
sequentially onto glass slides coated with poly-L-lysine. The
sections were deparaffinized with xylene and rehydrated
in graded ethanol, and then they were stained using the
EnVision method. The primary antibodies used consisted
of rat monoclonal antihuman CD44v6 and CEA (1:50,
Zhongshan, P.R. China), and the secondary antibodies
were purchased from the DAKO company. Diagnosis
standard (3): the numbers of positive cells were expressed
as the percentage of the total number of epithelial cells
and assigned to 1 of 4 categories: (-), 0%; (+), <25%; (++),
25%–50%; (+++), >50%.
2.3. Statistical analysis
Statistical analysis was performed by using SPSS
10.0. Fisher’s exact test or chi-square test was used in
enumeration of data, and the Spearman rank correlation
was used in correlation analysis.
3. Results
3.1 The expression of CD44v6 and CEA in CRC tissue,
paracarcinoma tissue, and normal colorectal mucosa
The positive CD44v6 expression was located in the cell
membrane, and its distribution was a continuous, girdleshaped buffer around the cell membrane. We noted the
expression of CD44v6 in CRC tissue, paracarcinoma
tissue, and normal colorectal mucosa. The positive CD44v6
expression was observed in 3/43 (7.0%) and 1/43 (2.3%)
samples of paracarcinoma tissue and normal colorectal
mucosa, respectively; however, the incidence of CD44v6
expression was significantly higher in CRC tissue (36/76,
47.4%, P < 0.001; Table 1).

The positive CEA expression was located in the
glandular cavity of epithelial cells of paracarcinoma tissue
and normal colorectal mucosa, and the incidence of
expression was observed in 6/43(14.0%) and 3/43(7.0%),
respectively. In CRC tissue, CEA expression was diffusely
located in the cytoplasm, membrane, and the cavity
of cancerous cryptae, and even located in the matrix.
The positive expression in CRC was observed in 68/75
(90.7%), with the delitescence of heteropolarity. The CEA
expression in CRC was significantly higher in CRC tissue
(P < 0.001; Table 1)
3.2. The expression of CD44v6 and CEA in CRC tissue,
and their relationship with clinical pathological features
The positive CD44v6 expression was observed in 67.7%
of cases of CRC with lymphoid metastasis. This was
significantly higher than in the group without lymphoid
metastasis (33.3%, P < 0.05). In the Dukes’ stage C+D
group, positive CD44v6 expression was 59.5%, statistically
higher than in the Dukes’ stage A+B group (35.9%, P <
0.05). In the poorly differentiated group it was 68.8%,
significantly higher than in the well and moderately
differentiated group (41.7%, P < 0.05). However, there
was not enough evidence to confirm that positive CD44v6
expression is significantly different in different gross types,
histological types, invasion depths, and distant metastasis.
The expression of CEA in CRC with lymphoid invasion
was significantly higher than in the group without lymphoid
invasion (P < 0.05). It was significantly higher in the group
with distant metastasis than in the group without distant
metastasis (P < 0.05). It was also significantly higher in the
T4 group than in the T2 group (P < 0.05) (Table 2).
3.3. The value of a positive expression of CD44v6 and
a high expression of CEA in the diagnosis of CRC
metastasis
In our study, the sensitivity and specificity of the expression
of these 2 cell adhesion molecules in the diagnosis of
CRC metastasis were different. For CD44v6 expression
they were 59.5% and 64.1%, and for CEA expression

Table 1. The expression of CD44v6 and CEA in CRC tissue, paracarcinoma tissue, and normal colorectal mucosa.

Lesion

CD44v6

CEA

Total

–

+

Positive rate

Total

–

+

Positive rate

NCM

43

42

1

2.3%*

43

40

3

7.0%*

PCT

43

40

3

7.0%*

43

37

6

14.0%*

CRC

76

40

36

47.4%

75

7

68

90.7%

*: Compared with CRC tissue, there was a significant difference (P < 0.001).
NCM: normal colorectal mucosa. PCT: paracarcinoma tissue.
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Table 2. The expression of CD44v6 and CEA in CRC tissue, and their relationship with clinical pathological features of the patients.

Clinical pathological features

CD44v6

CEA

n

–

+ (%)

n

-

+

++

+++ (%)

Protruding type

10

4

6 (60.0)

10

1

8

0

1 (10.0)

Localized ulceration

51

25

26 (51.0)

50

5

25

9

11 (22.0)

Invasive ulceration

15

11

4 (26.7)

15

1

8

4

2 (13.3)

Tubular adenocarcinoma

68

37

31 (45.6)

68

4

40

12

12 (17.6)

Mucinous adenocarcinoma +
signet-ring cell carcinoma

8

3

5 (62.5)

7

3

1

1

2 (28.6)

Well and moderately differentiated 60

35

25 (41.7)

60

4

36

9

11 (18.3)

Poorly differentiated

16

5

11 (68.8)*

15

3

5

4

3 (20.0)

T2

17

9

8 (47.1)

17

3

11

2

1 (5.9)

T3

41

22

19 (46.3)

40

3

24

7

6 (15.0)

T4

18

9

9 (50.0)

18

1

6

4

7 (38.9)**

+

31

10

21 (67.7)*

30

3

9

9

9 (30.0)*

-

45

30

15 (33.3)

45

4

32

4

5 (11.1)

+

13

6

7 (53.8)

13

1

4

2

6 (46.2 )*

-

63

34

29 (46.0)

62

6

37

11

8 (12.9)

A+B

39

25

14 (35.9)

39

3

28

3

5 (12.8)

C+D

37

15

22 (59.5)*

36

4

13

10

9 (25.0)

△

Gross types

Histological types

Differentiation

Depth of invasion

Lymph node metastasis

Distant metastasis

Dukes’ stages

: Positive or strong positive expressions.
*: Have significant difference compared to the control group (P < 0.05). **: Significantly higher than the T2 group (P < 0.05).
△

they were 25% and 87.2%, respectively. If compounded
in parallel, the sensitivity of CRC metastasis was 66.7%,
significantly higher than that by CEA expression alone (P
< 0.05). If compounded in series, the specificity was 92.3%,
significantly higher than that by CD44v6 expression alone
(P < 0.05) (Table 3).
3.4. The dependability of CD44v6 and CEA in CRC
tissues
In our study, the expression of CD44v6 was not correlated
with CEA in CRC tissues (Table 4).
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4. Discussion
Isoforms of CD44 are generated by the insertion of
alternative exons (V1–V11) at a single site within the
membrane-proximal portion of the extracellular domain
(4). Some research has shown that the different expression
style of CD44, and especially the variants, may play an
important role in the metastasis of various carcinomas
(5–9). CD44v6 has been proven in cell cultivation and
animal studies to be a metastasis-related gene. Recently,
CD44v6 was found to be closely related to the invasion and
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Table 3. The values of positive expression of CD44v6 and high expression of CEA in the diagnosis of CRC metastasis.
Nonmetastasis group

Metastasis group△

–

+

–

+

CD44v6

39

14

37

CEA

39

5#

Compounding in parallel

39

Compounding in series

39

Sensitivity

Specificity

22

59.5%

64.1%

36

9#

25.0%

87.2%

16##

36

24##

66.7%*

59.0%

3

36

7

19.4%

92.3%**

###

###

: Both lymph node metastasis and distant metastasis. *: Compared with the CEA group, P < 0.05. **: Compared with the CD44v6
group, P < 0.05. #: The expression of CEA > ++. ##: CD44v6 (+) or CEA > ++. ###: CD44v6 (+) and CEA > ++.
△

Table 4. The values of positive expression of CD44v6 and high expression of CEA in the diagnosis of CRC metastasis.

CD44v6

CEA
n

–

+

++

+++

+

36

3

17

6

10

–

39

4

24

7

4

metastasis of CRC (10). Chun et al. (11) found that a high
level of CD44v6 mRNA was transcripted in CRC tissues
compared with that in normal colorectal mucosa. In the
present study, the expression of CD44v6 in CRC tissues
(47.4%) was significantly higher than in paracarcinoma
tissue and normal colorectal mucosa (7.0% and 2.3%,
respectively) (P < 0.001). A recent study (12) also showed
that the positive expression of CD44v6 in CRC tissues can
even increase to 77.5%. Our and other teams’ results hint
that the high expression of CD44v6 was possibly related to
the initiation of CRC.
Most scientists (13–17) agree that the high expression
of CD44v6 is closely related to the development, invasion,
metastasis, and prognosis of CRC. Our results also show
that the positive expression of CD44v6 in CRC tissue with
lymph node metastasis was obviously higher than in the
group without lymph node metastasis (P < 0.05). The
expression in the Dukes’ stage C+D group was significantly
higher than in the Dukes’ stage A+B group (P < 0.05), and
in the poorly differentiated group it was significantly higher
than in the well and moderately differentiated group (P <
0.05). The above results indicate that the high expression
of CD44v6 was related to the lymph node metastasis of
CRC, which made it useful to evaluate the metastasis,
Dukes’ staging, and differentiation of CRC.
CEA is an important biomarker for treatment and
prognosis evaluation and a cell adhesion molecule for CRC
expression, which plays important roles in the recurrence

rs

P

0.183

>0.05

and metastasis of CRC. Using immunohistochemistry, we
can not only investigate the expression of CEA in CRC, but
we can also see the intact morphous cells and locate the
distribution of CEA more accurately than by investigating
the CEA level in the serum. We observed that in the tissue
beside the cancer tissue and normal colonic mucosa, the
expressions of CEA were low (14.0% and 7.0%, respectively),
but in cancer tissue the expression of CEA was observed
at 90.7%. In CRC, CEA is distributed in the cytoplasm,
membrane, and lumina, and even in the stroma, but in
normal tissue CEA is mostly located in the lumina.
In our study, the expression of CEA in CRC tissue
was enhanced when accompanied with a greater depth of
invasion. CEA expression in the T4 group was significantly
higher than in the T2 group (P < 0.05), which hints that
the expression of CEA was concerned with the invasion
potential of CRC. Our results are consistent with a previous
study (18). Additionally, the results show that positive
CEA expression was significantly higher in the group
with lymph node metastasis and in the group with distant
metastasis. The data suggest that CRC cells with high CEA
expression enter metastasis more easily. Furthermore,
Jessup et al. (19) found that a great number of CRC cells
come together with the help of the cell adhesion. We
speculate that CEA could enhance the life expectancy of
CRC cells and make the CRC cells have more success in
nidation in the target tissue, which ultimately increases the
invasion potential of CRC cells.
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In our study, the sensitivity of these 2 cell adhesion
molecules (CD44v6 and CEA) in the diagnosis of CRC
metastasis was 59.5% and 25%, respectively. The specificity
was 64.1% and 87.2%, respectively. If compounded in
parallel, the sensitivity of CRC metastasis was 66.7%, and
it was significantly higher than that just for CEA (P <
0.05). If compounded in series, the specificity was 92.3%,
significantly higher than that just for CD44v6 (P < 0.05).
We can therefore make our judgment as to whether the
metastasis has already occurred more accurately, and
this will provide useful reference for the follow-up visit,
adjunctive therapy, and prognosis of CRC.
Both CD44v6 and CEA belong to the cell adhesion
molecule family, mediating the interaction between
cancer cells, or cancer cells and the extracellular matrix,
so we presume that both of them may have compounding

functions in the process of invasion and metastasis of
CRC, which was already supported by the extraorgan
experiment. Ishii et al. (20) found that the adhesion
mediated by CEA between CRC cells can be blocked by
the CD44 monoclonal antibody, which indicated that
CEA and CD44 may share the same antibody determinant
group and cooperate in the adhesion process. In our study,
we did not show that the expression of CD44v6 and CEA
have significant dependability (P > 0.05). Whether the
action processes of CEA and CD44v6 are identical needs
further research.
In conclusion, CD44v6 is associated with the
occurrence and lymph node metastasis of CRC. The
expression of CEA is related to distant metastasis of CRC
positively. Combined analysis of CD44v6 and CEA can be
used to evaluate the metastasis of CRC.
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